Catalog No.
Product Name
Application
Product Information
Citations
-
Antibacterial Agent
epi-Equisetin is a secondary metabolite known for its antibacterial properties. It exhibits significant activity against a range of bacterial strains, making it a valuable compound for research into antimicrobial therapeutics. This compound is suitable for investigations into bacterial resistance mechanisms and the development of new antibacterial agents. -
Anti-Bacterial Agent
Citreamicin η is an anti-bacterial agent that primarily targets Gram-positive aerobic and anaerobic bacteria. This compound demonstrates significant antibacterial activity, making it a valuable tool for research applications in microbiology and infectious disease studies. Its efficacy against a range of Gram-positive organisms provides insights into bacterial resistance mechanisms and potential therapeutic strategies. -
Anti-Bacterial Agent
Dioxamycin is an anti-bacterial agent primarily targeting Gram-positive bacteria. It demonstrates significant inhibitory activity against Staphylococcus aureus 209P, with a minimum inhibitory concentration (MIC) of 3.12 μg/mL. Additionally, Dioxamycin exhibits cytotoxic effects on various cancer cell lines, including L1210, P388, IMC, LX-1, and SC-6, with IC50 values ranging from 1.4 to 6.0 μg/mL, highlighting its potential applications in antibacterial and anticancer research. -
Anti-Bacterial Agent
Paulomycin A2 is an anti-bacterial agent that targets Gram-positive bacteria. It demonstrates inhibitory activity against Staphylococcus aureus strains that are resistant to penicillin, streptomycin, neomycin, and macrolide antibiotics. This compound is useful in research applications focused on developing new antimicrobial therapies and studying bacterial resistance mechanisms. -
Antibacterial Agent
NAI-802 is a novel lantibiotic that acts as an antibacterial agent. It exhibits potent activity against Gram-positive anaerobic bacteria, including Clostridium difficile, C. butyricum, C. perfringens, and Peptostreptococcus asaccharolyticus, with minimum inhibitory concentration (MIC) values ranging from 0.25 to 2 μg/mL. This compound is a valuable tool for research focused on the mechanisms of bacterial resistance and the development of new antimicrobial therapies. -
Anti-Bacterial Agent
Saquayamycin A1 is an anti-bacterial agent known for its antimicrobial properties, exhibiting selective activity predominantly against Gram-positive bacteria. Additionally, it demonstrates inhibitory effects on leukemia P388 cells as well as Adriamycin-resistant P388 cells, making it a useful tool for studying drug resistance in cancer research. Its biological activity positions it as a potential candidate for further investigations in both anti-bacterial and anti-cancer applications. -
Anti-Bacterial Agent
Nisamycin is an anti-bacterial agent primarily effective against Gram-positive bacteria, exhibiting limited activity against certain Gram-negative bacteria and fungi. It demonstrates a weak cytotoxic effect, with an IC50 value of 4.8 μg/mL in mouse leukemia P388 cells. Nisamycin is suitable for research applications focused on studying bacterial infections and evaluating antimicrobial resistance mechanisms. -
Anti-Bacterial Agent
20-Deoxynarasin is an anti-bacterial agent that exhibits activity against Gram-positive bacteria, mycoplasma, coccidia, and certain viruses. This compound is relevant for research applications focused on evaluating antibacterial efficacy and growth promotion in various organisms. Its versatile biological activity makes it a useful tool in studies targeting infectious diseases and microbial growth regulation. -
Anti-Bacterial Agent
Amicenomycin A is an anti-bacterial agent that demonstrates potent activity against Gram-positive bacteria. This compound is useful in research focused on developing new antibiotics and studying bacterial resistance mechanisms. Its mechanism of action may provide insights into the efficacy and potential applications in treating bacterial infections. -
Anti-Bacterial Agent
Paulomycin B is an anti-bacterial agent that specifically targets Gram-positive bacteria. It exhibits significant inhibitory activity against penicillin-resistant Staphylococcus aureus, as well as strains resistant to Streptomycin, Neomycin, and Macrolide antibiotics. This compound is valuable for research focused on antibiotic resistance and the development of new therapeutic strategies against bacterial infections. -
Antibacterial Agents
Islandicin is an anthraquinone compound known for its antibacterial properties. Isolated from almonds, it exhibits significant activity against various bacterial strains. This compound is applicable in research focused on antimicrobial mechanisms and the development of new antibacterial agents. -
Anti-Bacterial Agent
Midecamycin A3 is a macrolide antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity against various strains, while also demonstrating limited efficacy against Gram-negative bacteria, mycobacteria, and fungi. This compound is useful in microbiological research and the study of bacterial resistance mechanisms. -
Anti-Bacterial Agent
Senfolomycin B is an anti-bacterial agent that primarily targets Gram-positive bacteria and mycobacteria. It exhibits efficacy against penicillin-resistant Staphylococcus aureus, as well as bacteria resistant to Streptomycin, Neomycin, and Macrolide antibiotics. Additionally, Senfolomycin B demonstrates a weaker activity against Gram-negative bacteria, making it a valuable compound for research on antibiotic resistance and bacterial infections. -
Antibacterial Agent
MAC-0018315 acts as an antibacterial agent, primarily targeting bacterial cell wall synthesis. This compound exhibits significant inhibitory activity against a range of Gram-positive and Gram-negative bacteria. It is utilized in research applications focused on understanding bacterial resistance mechanisms and the development of novel antimicrobial therapies. -
Anti-Bacterial Agent
Roseorubicin A primarily targets Gram-positive bacteria and exhibits significant anti-mycobacterial activity. It is effective against leukemia L1210 cells, exhibiting an IC50 of 0.04 μg/mL. This compound serves as a valuable tool for research in antimicrobial efficacy and cancer studies. -
Antibacterial Agent
13-HPOT is a linolenic acid hydroperoxide that functions as an antibacterial agent by interacting with lipid components of bacterial inner membranes. It exhibits dose-dependent antibacterial activity in vitro against a range of pathogens, including Pectobacterium carotovorum, Pseudomonas syringae pv. syringae DC3000, and Xanthomonas translucens pv. translucens. This compound is valuable for research applications aimed at understanding bacterial stress responses and developing new antimicrobial strategies. -
Antibacterial Agent
S-25932 is a potent 4-quinolone antibacterial agent targeting gram-negative bacteria. It demonstrates significant antibacterial efficacy against various strains, including Enterobacter aerogenes, Enterobacter adhlomerans, Enterobacter cloacae, and Escherichia coli, with MIC90 values of 1.0, 2.0, 1.0, and 0.25 µg/mL, respectively. This compound is applicable for research into antibacterial therapies and microbiological studies. -
Anti-Bacterial Agent
Fluoropolyoxin L is an antibacterial agent that exhibits potent inhibitory activity against Escherichia coli and Streptococcus faecalis. This compound is valuable for research applications focused on understanding bacterial resistance mechanisms and the development of novel antimicrobial strategies. Its targeted activity makes it an essential tool for microbiological studies and antibiotic research. -
Anti-Bacterial Agent
Oxirapentyn is an anti-bacterial agent primarily targeting Gram-positive bacteria and Mycobacterium species. While its antibacterial activity is relatively weak, it serves as a valuable compound for exploring bacterial resistance mechanisms and developing new antimicrobial strategies in pharmaceutical research. Its applications include studying the effects of bacterial infections and assessing potential therapeutic approaches in the field of infectious diseases. -
Antibacterial Agent
(Rac)-LY 255262 is a pyrazolidinone derivative that functions as an antibacterial agent. It effectively inhibits bacterial growth, making it suitable for research into antimicrobial resistance and the development of new antibacterial therapies. This compound is particularly useful for studies focused on the mechanisms of bacterial infections and potential therapeutic interventions. -
Antibacterial Agent
Agrimol C is a phloroglucinol derivative that exhibits antibacterial properties, primarily targeting Staphylococcus aureus. It demonstrates a minimum inhibitory concentration (MIC) of 50 μg/mL, indicating its effectiveness against this pathogenic strain. Agrimol C is suitable for research focused on infections and the development of antibacterial agents. -
Antibacterial Agent
Antibacterial Agent 135 is a potent antibacterial compound targeting multiple bacterial strains. It demonstrates inhibitory activity against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae, with an MIC greater than 64 μg/mL. This agent is valuable for research applications focusing on combating antibiotic-resistant infections and studying bacterial resistance mechanisms. -
Antibacterial Agent
4-Nitrosodiphenylamine is an antibacterial agent exhibiting significant activity against Erwinia amylovora, with an EC50 value of 5.715 mg/L. This compound is suitable for research applications focused on plant pathology and antibiotic development. Its effectiveness against specific bacterial strains makes it a valuable tool for studying antibacterial mechanisms and developing new therapeutic strategies. -
Antibacterial Agent
Ashimycin B is an antibacterial agent that functions as a Streptomycin analogue. It exhibits broad-spectrum antibacterial activity, making it suitable for research applications in microbiology, particularly in the study of antibiotic resistance mechanisms and the development of new antimicrobial therapies. Its efficacy against various bacterial strains highlights its potential as a valuable tool in the fight against bacterial infections. -
Anti-Bacterial Agent
Thiocillin is a thiopeptide classified as a Ribosomally Synthesized and Post-Translationally Modified Peptide (RiPP) that targets the bacterial 50S ribosomal subunit. It demonstrates significant antibacterial activity against various antibiotic-resistant pathogens, making it a valuable tool in the study of bacterial resistance mechanisms and the development of new antimicrobial therapies. Its effectiveness and unique mechanism of action position thiocillin as a promising candidate for research in infectious disease and antibiotic discovery. -
Anti-Bacterial Agent
Manumycin E is an anti-bacterial agent primarily targeting Gram-positive bacteria, with notable activity against Escherichia coli. It inhibits RAS Faraday base transfer, demonstrating a cytotoxic effect on human cancer cell lines, specifically HCT-116, with an IC50 of 15.6 μg/mL. Due to its limited efficacy against Gram-negative bacteria and fungi, Manumycin E may be primarily utilized in research focused on Gram-positive infections and cancer biology. -
Antibacterial Agent
3-Aminoisonicotinohydrazide is an antibacterial agent that primarily targets Mycobacterium tuberculosis. This compound demonstrates significant inhibitory activity against the pathogen, making it a valuable tool for research into tuberculosis and related infectious diseases. Its efficacy in antibacterial studies supports investigations into new treatment regimens and therapeutic strategies. -
Anti-Bacterial Agent
Azetomycin II is an anti-bacterial agent primarily effective against Gram-positive bacteria. It exhibits potent inhibitory activity against a variety of pathogenic strains, making it a valuable tool in the study of bacterial infections. Azetomycin II is commonly utilized in research focused on antimicrobial resistance and the development of new therapeutic strategies. -
Anti-Bacterial Agent
N-(2,6-Diamino-6-hydroxymethylpimelyl)-L-alanine functions as an anti-bacterial agent, demonstrating significant activity against Escherichia coli. When combined with various cell wall synthesis inhibitors such as Fosfomycin, Cycloserine, Penicillin, and Cephalosporin, it exhibits a pronounced synergistic antibacterial effect. This compound is valuable for research into antibacterial therapies and mechanisms of resistance. -
Anti-Bacterial Agent
Kibdelin D is an anti-bacterial agent that exhibits resistance against Gram-positive bacteria, particularly demonstrating potent activity against Staphylococcus aureus, including methicillin-resistant strains. Its mechanisms of action make it an important candidate for research into alternative treatments for bacterial infections, particularly in the context of increasing antibiotic resistance. -
Antibacterial Agent
cOB1 pheromone is a bacterial sex pheromone that functions as an antibacterial agent. It has been shown to effectively inhibit the growth of multidrug-resistant Enterococcus faecalis V583, making it a valuable tool for research into combating antibiotic resistance. Its unique mechanism of action highlights its potential applications in the study of bacterial communication and resistance mechanisms. -
Antibacterial Agent
CL-55 is an antibacterial agent that inhibits the type three secretion system of Chlamydia trachomatis, preventing the delivery of effector molecules into host cells. This compound has demonstrated efficacy in mitigating C. trachomatis infection and associated inflammation in murine models, highlighting its potential in therapeutic research for sexually transmitted infections. CL-55 serves as a vital tool for studying the pathogenic mechanisms of Chlamydia and developing effective treatment strategies. -
Antibacterial Agent/Photosensitive Agent
Fenticlor is a topical antibacterial agent that primarily targets skin bacteria involved in acne development. This compound is known to elicit photosensitivity reactions, leading to potential phototoxic dermatitis upon exposure to light. Its biological activity makes it useful in dermatological research focused on acne treatments and the mechanisms of skin sensitivity. -
Anti-Bacterial Agent
Pacidamycin 6 is an anti-bacterial agent targeting various bacterial strains, including Pseudomonas aeruginosa, Staphylococcus spp., and Escherichia coli. This compound demonstrates significant inhibitory effects on these pathogens, making it a valuable tool for studying bacterial infections. Notably, its antibacterial activity is influenced by serum components and pH levels, highlighting the importance of environmental conditions in its efficacy. Researchers can utilize Pacidamycin 6 for investigations into antibiotic resistance and bacterial pathogenesis. -
Antibacterial Agent
LY173013 is an antibacterial agent that exhibits broad-spectrum activity against a variety of bacterial strains. It targets penicillin-binding protein 3 (PBP 3) in Escherichia coli, effectively inhibiting bacterial cell wall synthesis. This compound is suitable for research applications in the study of antibacterial mechanisms and potential therapeutics for bacterial infections. -
Bacterial Inhibitor
INF55 is a multidrug resistance pump inhibitor targeting bacterial efflux mechanisms. By inhibiting the NoA pump, INF55 enhances the antibacterial efficacy of compounds such as berberine, reducing their efflux and overcoming bacterial resistance. Structural variants of INF55 demonstrate diverse NoA inhibitory activities, which can influence the antibacterial effectiveness of their respective heterocomplexes. This versatility makes INF55 and its derivatives valuable tools in the study and development of novel antimicrobial strategies. -
Antibacterial Agent
FOL7185 is an antibacterial agent that targets the IspD and IspE enzymes found in bacterial species. This compound exhibits potent inhibitory activity, disrupting critical biochemical pathways involved in bacterial cell wall biosynthesis. FOL7185 is useful for research applications aimed at understanding bacterial resistance mechanisms and developing novel antimicrobial therapies. -
Anti-Bacterial Agent
Pacidamycin 4 is an anti-bacterial agent with a primary mechanism of inhibiting Pseudomonas aeruginosa. It also exhibits activity against several other bacterial strains, including Staphylococcus aureus and Escherichia coli. The antibacterial efficacy of Pacidamycin 4 is influenced by serum and is affected by variations in pH, making it important for researchers to consider these factors in experimental design. This compound is valuable for studies exploring bacterial resistance and the development of novel antimicrobial therapies. -
Anti-Bacterial Agent
Gilvocarcin E is an anti-bacterial agent that primarily targets Gram-positive bacteria. It exhibits significant biological activity against various strains, as well as inhibitory effects on sarcoma 180 and P388 leukemia cells. This compound is valuable for research in microbiology and cancer biology, providing insights into bacterial resistance and potential therapeutic approaches. -
Antibiotic Intermediate
7-APRA is a semi-synthetic intermediate of cephalosporin antibiotics, targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity and serves primarily in the synthesis of other antibiotics, such as Cefaclor and Cefprozil. This compound is valuable in microbiological research and the development of cephalosporin-based therapeutics. -
Anti-Bacterial Agent
Fumaryl-DL-alanine, recognized for its antibacterial properties, primarily targets Gram-positive bacteria. This compound exhibits significant activity against bacterial strains, making it a valuable tool for research in antimicrobial efficacy and mechanism of action studies. Its properties facilitate investigations into bacterial resistance and the development of new antibacterial agents. -
Bacterial Inhibitor
Racemomycin B is a potent bacterial inhibitor derived from Streptomyces lavendulae OP-2, characterized as a streptothricin antibiotic with three β-lysine groups. It demonstrates significant antimicrobial activity against plant pathogenic microorganisms, effectively inhibiting the root growth of Brassica rapa L. at a concentration of 50 ppm. Racemomycin B exhibits a minimum inhibitory concentration (MIC) of 0.4 μg/ml against Pseudomonas syringae pv. tabaci IFO-3508 and a MIC range of 0.1-2.0 μg/ml against various strains of Fusarium oxysporum. The biological efficacy of this compound is enhanced by the increasing number of β-lysine groups, making it a valuable tool for agricultural research. -
Anti-Bacterial Agent
Glysperin C is an anti-bacterial agent targeting both Gram-positive and Gram-negative bacteria, including those resistant to aminoglycoside antibiotics. Its broad-spectrum activity makes it a valuable tool for research into bacterial resistance mechanisms and the development of new therapeutic strategies against various infectious diseases. -
Anticancer Agent
Previridicatumtoxin is a fungal metabolite known for its antibacterial and anticancer properties. Derived from the organism P. aethiopicum, this compound demonstrates significant biological activity against cancer cells and has potential applications in cancer research and studies related to infections. Its unique mechanism of action makes it a valuable tool for exploring therapeutic strategies in oncology and microbiology. -
Antibacterial Agent
Octenidine (saccharin) is a potent antibacterial agent that targets multidrug-resistant Gram-negative pathogens. This compound exhibits significant activity by inhibiting the expression of biofilm-associated genes, which disrupts biofilm formation. Its unique properties make it valuable for research applications focused on combating antibiotic resistance and biofilm-related infections. -
Anti-Bacterial Agent
Diatretyne I is an anti-bacterial agent that exhibits selective activity against Gram-positive bacteria. This compound demonstrates potential in addressing bacterial infections and may serve as a valuable tool in microbiological research for evaluating antibacterial efficacy and understanding resistance mechanisms. -
Anti-Bacterial Agent
Galacardin B is an anti-bacterial agent that specifically targets Gram-positive bacteria. It exhibits potent bactericidal activity, making it valuable in research focused on developing treatments for infections caused by resistant bacterial strains. This compound serves as a critical tool for scientists investigating antibacterial mechanisms and therapeutic options in microbiology. -
Antibacterial Agent
Palmitanilide is an antibacterial agent that specifically targets Gram-positive bacteria. It exerts its activity by electrostatically binding to components within the bacterial cell wall, leading to alterations in cell membrane structure and disruption of normal cell functions. This compound shows promise for research applications focused on infectious diseases caused by Gram-positive pathogens, such as Bacillus cereus. -
Anti-Bacterial Agent
Fosfocytocin is an antibacterial agent derived from the strain of Pseudomonas fluorescens PK-52. It exhibits low antibacterial activity, making it a subject of interest for studying bacterial resistance mechanisms. This compound may serve as a valuable tool in research applications focused on antimicrobial peptides and their interactions with bacterial pathogens. -
Anti-Bacterial Agent
Chlorocardicin is a monocyclic beta-lactam antibiotic that primarily targets bacterial cell wall synthesis. It demonstrates moderate in vitro activity against Enterobacteriaceae and Pseudomonas aeruginosa, making it a valuable tool for studying bacterial infections and resistance mechanisms. This compound is applicable in research focused on antibiotic development and evaluating the efficacy of beta-lactam antibiotics.
